血液透析(HD)联合药物、血液灌流治疗重症尿毒症的临床疗效对比分析

Comparative analysis of clinical efficacy of hemodialysis(HD) combined hemoperfusion and drug therapy for severe uremia

目的:探讨重症尿毒症患者接受血液透析(HD)联合药物、血液灌流方案进行治疗的临床效果及推广价值.方法:选取2008-02/2014-08我院收治的确诊为重症尿毒症的患者80例,以随机数字表方式分为对照组(n=40)和观察组(n=40),对照组采取常规血液透析法治疗,观察组采取常规治疗联合药物、血液灌流法治疗.比较两组患者的治疗效果.结果:观察组的临床疗效显著优于对照组,差异具有统计学意义(P<0.05).结论:相对于常规血液透析治疗,对重症尿毒症患者应用血液透析联合药物、血液灌流治疗方案,对保障患者身体健康以及生活质量有重要价值,值得临床推广.

AIM： To investigate the clinical effect and value of the treatment of hemodialysis（ HD） combined hemoperfusion and drug therapy for severe uremia. METHODS： A total of 80 cases of severe uremic patients admitted into our hospital from February2008 to August 2014 were randomly divided into control group（ n= 40） and observation group（ n = 40）. The control group was given conventional hemodialysis treatment,and the observation group was given conventional hemodialysis combined drug treatment,hemoperfusion. The clinical efficacy of the two groups were compared. RESULTS： The total effective rate was 95.00% in the observation group,while the total effective rate was 80.00% in the control group,and the observation group was superior to the control group. There was statistically significant difference between the two groups（ P〈0. 05）. CONCLUSION： Compared with conventional hemodialysis treatment,the conventional hemodialysis combined drug,hemoperfusion treatment is of significant value in protecting the health and living quality,and it is worthy of clinical promotion.